Position in PBH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,274,785
-$5,257,106 QoQ
Shares Held
55,252
-55.4% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. PBH ranks #18 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
9,349,817 | $126,316,026 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
508,977 | $67,052,628 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
611,747 | $46,401,008 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
75,977 | $45,052,841 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
2,664,306 | $36,900,638 | |
| 6 | ALKS |
Alkermes plc.
|
999,322 | $35,336,024 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,382,412 | $33,081,118 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
748,812 | $24,763,212 |
All Filings in PBH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,274,785 | 55,252 | Shares | Other | 2026-05-15 | |
| 2024-06-30 | $8,531,891 | 123,920 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $8,433,213 | 116,224 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $5,616,935 | 91,750 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,418,826 | 24,809 | Shares | Other | 2023-11-14 | |
| 2022-03-31 | $4,296,133 | 81,151 | Shares | Other | 2022-05-16 | |
| 2020-09-30 | $1,386,072 | 38,058 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $854,497 | 23,296 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||